3rd Quarter & 9 Mths Results
Zen Research PLC
25 October 2000
Zen Research plc
Third quarter results
for the three months ended 30 September 2000
Zen Research plc, the developer and licensor of Multibeam and
True X technologies for use in production of high-performance
components for DVD and CD drives, today announces results for the
third quarter ended 30 September 2000.
Zen's objective is to establish its Multibeam and True X
technologies as leading industry solutions for optical storage
devices.
HIGHLIGHTS
* Research and development of multiple beam DVD technology and
products continues to move ahead:
- Pre-production Multibeam DVD optical detector elements
shipped
- DVD controller chip taped out in September
* Two additional DVD drive manufacturers, Afreey and Actima of
Taiwan, were licensed
* Two further patents granted: one in optics and the other in
software
* US$5 million acquisition of optical write technology through a
licensing arrangement
* Successful IPO in July 2000 raising approximately US$98
million net of expenses
Emil Jachmann, Chief Executive of Zen Research plc said:
'Following our successful IPO, we commenced a substantial
increase in research and development in an effort to advance Zen
technology as an industry solution for high performance DVD and
CD drives.
'With our optic and drive license partners in Japan, Korea, and
Taiwan, we now have a presence in the three largest centers for
optical drive production. We remain confident that our strategy
will continue to attract additional licensing partners.'
For further information:
Zen Research
Emil Jachmann, David Aber Tel: 0044 20 7382 0470
Bell Pottinger Financial
Jonathon Brill/Mark Way Tel: 0044 20 7353 9203
www.zenresearch.com
ADDITIONAL INFORMATION
Infineon Technologies successfully taped out their Raptor DVD
chip last month, and plans to have the first pre-production chip
samples fabricated before year-end. The Zen licensed chip will
serve as the central controller in True X DVD-ROM drives.
EM (US) Design, Inc., a subsidiary of the Swatch Group, who
signed a Zen technology license earlier this year, has started
delivering pre-production Multibeam detector elements for
testing and integration into optical pick up assemblies for True
X DVD-ROM drives.
During October 2000, Zen executed a US$ 5 million licensing
agreement to acquire rewrite technology rights from Calimetrics,
a US company that has developed unique rewrite technology that is
applicable to standard rewritable CD and DVD. Zen believes that
this rewrite technology will complement its core technologies and
supplement Zen's entry into the rewritable optical drive market
segments.
Zen was granted two additional patents during the 3rd quarter.
One relates to the use of multiple beam optics and their
interface with silicon and the other relates to software that
processes data collected in parallel. The patents strengthen
Zen's IP portfolio, which now totals 23 issued patents.
FINANCIAL COMMENTARY
During July 2000, Zen floated on the London Stock Exchange
raising approximately US$98 million (£65 million) after expenses,
which included the Underwriters' Option.
TURNOVER
Turnover for the three month and nine month periods ended 30
September 2000 represent royalty income received under a license
agreement with a single licensee for CD ROM technology only.
Turnover for the three month and nine month periods ended 30
September 1999 represents the sale of CD-ROM ASICs (Application
Specific Integrated Circuits) which were made prior to the
conversion of Zen's business model.
During mid 1999, Zen converted from a business model which
recognised turnover from the direct sale of CD-ROM ASIC's, to its
current business model in which Zen is primarily engaged in
product design and development of technology which is licensed
for use in the production of high-performance components for CD
and DVD optical storage devices.
RESEARCH AND DEVELOPMENT
Research and development expenses increased during the three
month and nine month periods ended 30 September 2000 compared to
the corresponding prior year period due to the increase in
headcount and related expenses and expenditures on outside
engineering services to develop and enhance Zen's intellectual
property. Zen expects further increases in the future.
COSTS IN CONNECTION WITH THE INITIAL PUBLIC OFFERING
Zen incurred a total of US $15,872,000 of costs in relation to
the Initial Public Offering and offering of new shares.
Expenses, which were incurred directly in connection with the
issue of new shares, including an apportionment of costs relating
to the offering of both new shares and the existing shares in the
Initial Public Offering, have been charged to the share premium
account. The costs related to the offering of both new shares
and existing shares in the Initial Public Offering, have been
apportioned on the basis of the number of new shares offered
against the total of new and existing shares at the time of the
Initial Public Offering. Of the total costs, US $10,066,000 has
been charged against the share premium account and US $5,806,000
to the Profit and Loss statement.
OTHER OPERATING EXPENSES
The increase in other net operating expenses for the three month
period ended 30 September 2000, compared to the corresponding
prior year three month period, was mainly due to higher costs
related to being a public company, including increased insurance,
the establishment of two additional corporate entities and other
related costs. Zen expects such increases to continue. Other
net operating costs for the nine month period ended 30 September
2000 compared to the corresponding prior year periods decreased
due to Zen's change in business model as discussed above. The
reduction in costs during this period reflects the decrease in
headcount and related expenses deployed in field operations,
which had been important to support the prior business model.
CONSOLIDATED BALANCE SHEET
Cash on hand increased at 30 September 2000 compared to 31
December 1999 due to the successful public offering on the London
Stock Exchange, issuance of pre-IPO preferred stock to several
investors (which was converted to ordinary shares in the IPO) and
the exercise of options for Ordinary shares. Proceeds from these
issuances were partially used to reduce the outstanding amount
due to creditors falling due within one year.
Zen Research plc
Results for the quarter and nine months ended 30 September 2000
Consolidated profit and loss accounts
Quarter ended 9 months ended
30 September 30 September
2000 1999 2000 1999
Unaudited Unaudited
US$ '000 US$ '000
Turnover 41 94 161 100
Cost of sales -- (69) -- (74)
--------- --------- --------- ---------
Gross profit 41 25 161 26
Research and
development (2,077) (1,434) (5,654) (4,028)
Costs in
connection with
the Initial
Public Offering (5,806) -- (5,806) --
Other net
operating
expenses (1,301) (1,248) (3,274) (4,506)
--------- --------- --------- ---------
Operating
expenses (9,184) (2,682) (14,734) (8,534)
Loss on ordinary
activities before
interest and
taxation (9,143) (2,657) (14,573) (8,508)
Net interest
receivable/
(payable) 1,195 (77) 609 (314)
--------- --------- --------- ---------
Loss on ordinary
activities before
taxation (7,948) (2,734) (13,964) (8,822)
Taxation on
ordinary
activities (384) (55) (459) (127)
--------- --------- --------- ---------
Loss on ordinary
activities after
taxation (8,332) (2,789) (14,423) (8,949)
========= ========= ========= =========
Basic loss per
share(US dollars) (0.05) (0.03) (0.11) (0.12)
========= ========= ========= =========
Weighted Average
Ordinary Shares 175,403,592 82,007,891 127,246,614 73,179,390
============ ========== ============ ==========
Zen has no recognised gains and losses in any of the periods
shown above other than the loss for the period shown in the
relevant profit and loss account. Accordingly, no separate
statement of total recognised gains and losses has been
presented.
Zen Research plc
Consolidated balance sheet
30 September 31 December 30 September
2000 1999 1999
Unaudited Audited Unaudited
US$ '000 US$ '000 US$ '000
Fixed assets
Intangible assets 285 548 635
Tangible assets 1,348 1,522 1,787
--------- --------- ---------
1,633 2,070 2,422
Current assets
Debtors - due after
more than one year 1,572 2,244 2,235
Debtors - due within
one year 581 157 525
--------- --------- ---------
2,153 2,401 2,760
Cash at bank and in
hand 100,507 90 679
--------- --------- ---------
102,660 2,491 3,439
Creditors - Amounts
falling due within one
year (4,432) (10,490) (11,171)
--------- --------- ---------
Net current liabilities 98,228 (7,999) (7,732)
--------- --------- ---------
Total assets less
current liabilities 99,861 (5,929) (5,310)
Creditors - Amounts
falling due after more
than one year (3,962) (384) (364)
--------- --------- ---------
Net
assets/(liabilities) 95,899 (6,313) (5,674)
--------- --------- ---------
Capital and reserves
Called up share capital 13,397 642 482
Share premium 110,628 33,843 31,575
Other reserves 27,827 732 732
Profit and loss account (55,953) (41,530) (38,463)
--------- --------- ---------
Total shareholders'
funds 95,899 (6,313) (5,674)
========= ========= =========
Zen Research plc
Consolidated cash flow statement
Quarter ended 9 months ended
30 September 30 September
Unaudited Unaudited
US$ '000 US$ '000
2000 1999 2000 1999
Net cash outflow from
operating activities (12,277) (1,455) (18,244) (5,086)
Returns on investments
and servicing of
finance
Interest received 1,603 5 1,660 22
Interest paid (65) (82) (323) (336)
------- ------- ------- -------
Net inflows/(outflows)
from returns on
investments and
servicing of finance 1,538 (77) 1,337 (314)
Capital expenditure
Purchase of fixed
assets (96) (335) (385) (548)
Sale of tangible fixed
assets -- -- -- --
------- ------- ------- -------
Net cash outflow for
capital expenditure (96) (335) (270) (548)
Increase in short-term
deposits with banks (43,431) -- (43,431) --
Financing
Proceeds from advances
in respect of royalties -- -- 3,000 --
Proceeds from initial
public offering 114,364 -- 114,364 --
Issue costs in respect
of initial public
offering (10,066) -- (10,066) --
Proceeds from issuance
of common and preferred
stock -- 2,001 9,366 2,030
Repayment of loan notes
due from shareholders 3,693 -- 4,197 --
-------- ------- -------- -------
Net cash inflow from
financing 107,991 2,001 120,861 2,030
-------- ------- -------- -------
Increase/(decrease) in
cash 53,725 134 60,253 (3,918)
======== ======= ======== =======
Notes to the Interim Financial Statements of Zen Research plc
1. Basis of preparation
The interim financial statements have been prepared on the
accounting policies set out in the accountants' report
included within Zen's listing particulars dated 26 June
2000. The financial information has been prepared under the
historical cost convention and in accordance with accounting
standards applicable in the United Kingdom.
2. Loss per share
Basic loss per share is calculated by dividing the loss
attributable to ordinary shareholders by the weighted
average number of ordinary shares in issue during the
period. Convertible preferred shares have been included for
all periods in the calculation of basic loss per share on
the basis that all the convertible preferred shares were
converted to ordinary shares and are outstanding for all
periods presented.
In calculating loss per share, no adjustment has been made
for share options granted and warrants for purchase of
ordinary shares, as the effect would be to reduce the loss
per Ordinary Share.
The financial information contained in this announcement does not
constitute statutory accounts within the meaning of Section 240
of the Companies Act 1985. Zen was incorporated on 30 December
1999, and no statutory accounts have yet been required to be
prepared and delivered to the Registrar of Companies by Zen.